Champlain Investment Partners’s Sanofi SNY Stock Holding History

Champlain Investment Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-5,000	Closed	-$237K	–	147
2015 Q3	$237K	Hold	5,000	–	–	﹤0.01%	139
2015 Q2	$248K	Hold	5,000	–	–	﹤0.01%	137
2015 Q1	$247K	Hold	5,000	–	–	﹤0.01%	126
2014 Q4	$228K	Buy	5,000 +1,200	+32%	+$58.2K	﹤0.01%	127
2014 Q3	$214K	Hold	3,800	–	–	﹤0.01%	136
2014 Q2	$202K	Buy	+3,800	New	+$202K	﹤0.01%	137

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Champlain Investment Partners's SNY Position: Q4 2015 in Review

Champlain Investment Partners sold out of Sanofi (SNY) in Q4 2015, closing a stake of 5,000 shares — an estimated $237K sold.

Champlain Investment Partners first reported a position in SNY in Q2 2014 and held it in 6 quarters. The position peaked at $248K in Q2 2015. 477 funds tracked by Wall St. Rank hold SNY as of Q4 2015.

Champlain Investment Partners reported no remaining Sanofi position as of Q4 2015 after selling out during the quarter.
Champlain Investment Partners sold 5,000 Sanofi shares in Q4 2015, an estimated $237K.
Champlain Investment Partners first reported a position in Sanofi in Q2 2014 and held it in 6 quarters.
Champlain Investment Partners's Sanofi position peaked at $248K in Q2 2015.
477 funds tracked by Wall St. Rank held Sanofi as of Q4 2015.

Based on Champlain Investment Partners's 13F filing for Q4 2015, filed 12 Feb 2016.